IL6 and colitis: LTA reduced the lipopolysaccharide (LPS)-mediated histological damage, decreased the level of TNF-α, IFN-γ, IL-6 and IL-1β and enhanced the intestinal permeability by increasing the expression of certain tight junction proteins in LPS-induced murine model of colitis.